$275 Million is the total value of KNOTT DAVID M's 197 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 105.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLMT | Buy | Calumet Specialty Products Partners, LP | $28,219,000 | +30.3% | 3,567,500 | +13.1% | 10.25% | +33.2% |
| New | Greenidge Generation Holdings Inc.put | $11,462,000 | – | 448,809 | +100.0% | 4.16% | – | |
| New | Coliseum Acquisition Corp | $9,563,000 | – | 984,835 | +100.0% | 3.48% | – | |
| KDMN | Buy | Kadmon Holdings, Inc. | $8,618,000 | +165.7% | 989,450 | +18.0% | 3.13% | +171.6% |
| MDWT | Buy | Midwest Holding Inc. | $6,613,000 | +2.2% | 170,000 | +3.0% | 2.40% | +4.5% |
| New | Greenidge Generation Holdings Inc. | $5,721,000 | – | 224,000 | +100.0% | 2.08% | – | |
| New | Coliseum Acquisition Corp. Wts | $5,693,000 | – | 495,000 | +100.0% | 2.07% | – | |
| BRIV | New | B.Riley Principal 250 Merger Corp. | $3,395,000 | – | 350,000 | +100.0% | 1.23% | – |
| HZAC | New | Horizon Acquistion Corporation | $2,097,000 | – | 210,100 | +100.0% | 0.76% | – |
| EIGR | Buy | Eiger BioPharmaceuticals, Inc. | $2,087,000 | -14.5% | 312,492 | +9.1% | 0.76% | -12.7% |
| MSAC | New | Medicus Science Acquisition, Corp. | $1,950,000 | – | 200,000 | +100.0% | 0.71% | – |
| INVA | Buy | Innoviva, Inc. | $1,926,000 | +200.5% | 115,269 | +141.2% | 0.70% | +207.0% |
| INCY | New | Incyte Corporation | $1,821,000 | – | 26,475 | +100.0% | 0.66% | – |
| CHRS | Buy | Coherus Biosciences, Inc. | $1,648,000 | +19.6% | 102,555 | +2.9% | 0.60% | +22.2% |
| BRIVW | New | B.Riley Principal 250 Merger Corp. Wts. | $1,342,000 | – | 116,666 | +100.0% | 0.49% | – |
| VZ | Buy | Verizon Communications | $972,000 | -2.0% | 17,991 | +1.6% | 0.35% | 0.0% |
| New | Doma Holdings, Inc. - Warrants | $958,000 | – | 83,333 | +100.0% | 0.35% | – | |
| MDLZ | Buy | Mondelez Int'l Inc. | $931,000 | -6.3% | 16,000 | +0.6% | 0.34% | -4.2% |
| DD | Buy | Dupont De Nemours Inc. | $826,000 | -11.9% | 12,160 | +0.3% | 0.30% | -9.9% |
| CLBR | New | Colombier Acquisition Corp. | $774,000 | – | 80,000 | +100.0% | 0.28% | – |
| DOW | Buy | Dow Inc. | $700,000 | -8.7% | 12,160 | +0.3% | 0.25% | -7.0% |
| New | Macquire Infrastructure Corp | $542,000 | – | 13,350 | +100.0% | 0.20% | – | |
| T | Buy | AT&T Inc. | $543,000 | -5.9% | 20,125 | +0.4% | 0.20% | -3.9% |
| CTVA | Buy | Corteva Inc. | $508,000 | -4.9% | 12,075 | +0.3% | 0.18% | -2.6% |
| CLBRWS | New | Colombier Acquisition Corp. Wts. | $307,000 | – | 26,666 | +100.0% | 0.11% | – |
| FSBW | Buy | FS Bancorp | $253,000 | -0.8% | 7,300 | +104.1% | 0.09% | +1.1% |
| TARA | Buy | Protara Therapeutics, Inc. | $252,000 | -28.4% | 36,479 | +0.9% | 0.09% | -26.4% |
| CDXS | New | Codexis, Inc. | $233,000 | – | 10,000 | +100.0% | 0.08% | – |
| VLY | Buy | Valley National Bancorp | $171,000 | +1.8% | 12,800 | +2.6% | 0.06% | +3.3% |
| XLRN | New | Acceleron Pharma, Inc. | $172,000 | – | 1,000 | +100.0% | 0.06% | – |
| SSB | Buy | South Street Corporation | $160,000 | -6.4% | 2,135 | +2.5% | 0.06% | -4.9% |
| TTE | Buy | Total SA | $120,000 | +7.1% | 2,500 | +1.6% | 0.04% | +10.0% |
| ZYME | New | Zymeworks Inc. | $116,000 | – | 4,000 | +100.0% | 0.04% | – |
| MRK | Buy | Merck & Co. Inc. | $111,000 | +9.9% | 1,475 | +13.5% | 0.04% | +11.1% |
| IOVA | New | Iovance Biotherapeutics, Inc. | $99,000 | – | 4,000 | +100.0% | 0.04% | – |
| SWBI | New | Smith & Wesson Brands | $85,000 | – | 4,097 | +100.0% | 0.03% | – |
| New | Tempest Therapeutics, Inc. | $78,000 | – | 5,359 | +100.0% | 0.03% | – | |
| CFFN | Buy | Capitol Federal | $46,000 | +2.2% | 4,000 | +5.3% | 0.02% | +6.2% |
| New | American Outdoor Brands | $25,000 | – | 1,024 | +100.0% | 0.01% | – | |
| SMIT | New | Schmitt Industries | $11,000 | – | 2,500 | +100.0% | 0.00% | – |
| OGN | Buy | Organon & Co. | $5,000 | +25.0% | 147 | +13.1% | 0.00% | +100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.